DIMENSION

Vivet Therapeutics SAS

This biotechnology company develops gene therapies using recombinant adeno-associated virus technologies to treat patients with rare, inherited metabolic liver diseases.

Code Bio

This company develops non-viral genetic medicine delivery platforms and therapies for patients with rare and prevalent genetic diseases.

Strategic Partners

This company develops drug candidates for serious genetic disorders to serve patients with rare diseases.

Stridebio

This company develops engineered viral vectors and gene therapies for patients with rare genetic diseases.

Dyno Therapeutics

The company designs adeno-associated virus vectors for gene delivery using artificial intelligence for biopharmaceutical and pharmaceutical partners.

Be Biopharma

This company develops engineered B cell medicines to treat patients with hemophilia B, genetic diseases, and cancer.

Borea Therapeutics

The company develops bio-conjugated viral vectors for gene therapy to treat patients with genetic or chronic diseases.

Shape Therapeutics

The company develops programmable RNA medicines and delivery systems for patients with genetic disorders and other hard-to-treat diseases.